Influenza News and Research

Latest Influenza News and Research

CSL Biotherapies initiates clinical trials of Influenza A/H1N1 2009 vaccine in the US

CSL Biotherapies has announced the initiation of the company’s first U.S. clinical trials of its candidate Influenza A/H1N1 2009 vaccine. Study investigators will administer vaccinations to the first U.S. study volunteers today, August 24. The studies will determine the safety of CSL’s candidate vaccine and its ability to elicit an immune response (also referred to as immunogenicity) in adults and children.

24 Aug 2009

National campaign to educate people with developmental disabilities about protection from germs

The Tech-Aid Institute, http://www.techaidinstitute.com, is launching a national campaign to educate people with intellectual and other developmental disabilities about how to protect themselves from germs that include the 2009 flu pandemic that is commonly known as the Swine (H1N1) Flu.

24 Aug 2009

Microbiologists discover new therapies for human respiratory syncytial virus and influenza A virus

A cellular molecule that not only can sense two common respiratory viruses but also can direct cells to mount a defense has been identified by microbiologists at The University of Texas Health Science Center at San Antonio.

24 Aug 2009

WHO recommends against using homeopathic treatments for HIV, TB, malaria, influenza, infant diarrhea

The WHO has warned that people with conditions such as HIV, tuberculosis and malaria should not rely on homeopathic treatments, the BBC reports. The agency was responding to a June letter (full text available here), in which researchers from the Voice of Young Science Network called on the agency "to condemn the promotion of homeopathy for treating TB, infant diarrhoea, influenza, malaria and HIV."

23 Aug 2009

'Explosion' of H1N1 cases likely, WHO Says

In the coming months, countries should prepare for an "explosion" in new cases of H1N1 (swine) flu until peak transmission of the virus is reached, WHO Western Pacific Director Shin Young-soo told a symposium of health officials gathered in Beijing Friday, the Associated Press reports.

23 Aug 2009

Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug

Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Naval Health Research Center for preclinical studies evaluating Adamas' triple combination antiviral drug (TCAD) therapy for influenza A, including novel influenza A/H1N1. TCAD therapy includes Adamas' investigational proprietary fixed-dose oral combination drug, to be administered adjunctively with a neuraminidase inhibitor, including Tamiflu (oseltamivir phosphate, Roche).

22 Aug 2009

Applied Nanoscience in joint venture agreement to produce disposable protective face mask

Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, today announced it has reached a joint venture agreement to begin production on a disposable protective face mask with its Asia Pacific region partner. The protective mask will incorporate ANI's proprietary NanoFense™ technology, a U.S. patent pending antimicrobial nanoparticle formulation.

21 Aug 2009

Study finds that vaccinations to schoolchildren and to their parents helps to control the spread of the seasonal flu and H1N1

Optimal control of the spread of the seasonal flu and H1N1 is achieved by prioritizing vaccinations for schoolchildren and for adults aged 30 to 39 in the United States. Those are the findings of a new study by Clemson University mathematician Jan Medlock and colleague Alison Galvani of the Yale University School of Medicine.

21 Aug 2009

Medicago and Ajanta Pharma forge MoU to commercialize seasonal influenza VLP-based vaccines in India

Medicago Inc., a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has signed a Memorandum of Understanding ("MOU") with Ajanta Pharma Limited ("Ajanta") to discuss and negotiate an agreement to commercialize Medicago's pandemic and seasonal influenza VLP-based vaccines in India and other territories.

21 Aug 2009

New study reveals that influenza vaccination may prevent inappropriate antibiotic use

We all know that influenza vaccination helps prevent disease, but a new study from Canada suggests it may also prevent another public health problem: inappropriate antibiotic use. The findings come from a new study in the September 1, 2009 issue of Clinical Infectious Disease, which is now available online.

21 Aug 2009

Influenza A H1N1 Real Time RT-PCR tests detect RNA of H1N1 influenza virus

Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, today announced that its Influenza A H1N1 (2009) Real Time RT-PCR test is now available as a test kit for use by "high complexity" clinical laboratories in the U.S.

21 Aug 2009

Federal guidelines for seasonal and swine flu vaccines questioned

With the seasonal flu season approaching and uncertainty over whether swine flu will become more severe, new research published by Yale School of Public Health has found that more people are likely to avoid illness if vaccines are given out first to those most likely to transmit viruses, rather than to those at highest risk for complications.

20 Aug 2009

WHO says confirmed H1N1 deaths worldwide reach 1,800

According to the latest WHO report out Wednesday, the number of confirmed H1N1 (swine) flu deaths since its emergence in April has reached 1,799 - a jump from 1,462 deaths since the agency's last update, Agence France-Presse/the Australian reports.

20 Aug 2009

Chemical components of elderberry, cinnamon and green tea extracts block HIV viruses from infecting cells

The development of new antiviral drugs has had a tremendous impact on the quality of life and life expectancy of HIV-positive and AIDS patients, as the drugs effectively disrupt the replication cycle of the HIV virus. Yet the regular use of those drugs - such as zidovudine (also known as azidothymidine or AZT), protease inhibitors, and highly active antiretroviral therapy (HAART) involving multidrug therapies - has led to resistant HIV strains.

20 Aug 2009

MedImmune, WPS and AYSO collaboratively launch a national health awareness campaign

MedImmune, Women's Professional Soccer (WPS) and the American Youth Soccer Organization (AYSO) today officially launched "Don't Play with the Flu,"((TM)) a national health awareness campaign that aims to highlight the importance of getting a seasonal influenza vaccination every year.

20 Aug 2009

Inovio Biomedical records $2.9 million revenues in the six months ended June 30, 2009

Inovio Biomedical Corporation (NYSE AMEX: INO) (“Inovio”) today reported financial results for the three and six months ended June 30, 2009. Total revenue of $2.5 million and $2.9 million for the three and six months ended June 30, 2009, compared to $663,000 and $1.3 million for the three and six months ended June 30, 2008, respectively.

20 Aug 2009

H1N1 vaccine administration coverage for eligible members of Anthem Blue Cross and Blue Shield in Maine

Anthem Blue Cross and Blue Shield in Maine has announced that it will offer coverage for the administration of the H1N1 (swine flu) vaccine when it becomes commercially available to the general public. The vaccine administration will be covered for members whose benefit plans provide coverage for vaccines.

20 Aug 2009

New guidance for businesses to plan for and respond to upcoming flu season

Department of Commerce (DOC) Secretary Gary Locke, Department of Health and Human Services (HHS) Secretary Kathleen Sebelius, and Homeland Security (DHS) Secretary Janet Napolitano today announced new guidance for businesses to plan for and respond to the upcoming flu season.

19 Aug 2009

AstraZeneca Canada files a New Drug Submission (NDS) for FluMist in Canada

AstraZeneca Canada Inc. announced today that it has filed a New Drug Submission (NDS) for FluMist(R) (Influenza Vaccine, Live Attenuated Intranasal) with Health Canada.

19 Aug 2009

U.S. Food and Drug Administration launches new Center for Tobacco Products

The U.S. Food and Drug Administration today launched its new Center for Tobacco Products in an historic effort to curb the hundreds of thousands of deaths caused by those products each year.

19 Aug 2009

Influenza News and Research

Latest Influenza News and Research

CSL Biotherapies initiates clinical trials of Influenza A/H1N1 2009 vaccine in the US

National campaign to educate people with developmental disabilities about protection from germs

Microbiologists discover new therapies for human respiratory syncytial virus and influenza A virus

WHO recommends against using homeopathic treatments for HIV, TB, malaria, influenza, infant diarrhea

'Explosion' of H1N1 cases likely, WHO Says

Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug

Applied Nanoscience in joint venture agreement to produce disposable protective face mask

Study finds that vaccinations to schoolchildren and to their parents helps to control the spread of the seasonal flu and H1N1

Medicago and Ajanta Pharma forge MoU to commercialize seasonal influenza VLP-based vaccines in India

New study reveals that influenza vaccination may prevent inappropriate antibiotic use

Influenza A H1N1 Real Time RT-PCR tests detect RNA of H1N1 influenza virus

Federal guidelines for seasonal and swine flu vaccines questioned

WHO says confirmed H1N1 deaths worldwide reach 1,800

Chemical components of elderberry, cinnamon and green tea extracts block HIV viruses from infecting cells

MedImmune, WPS and AYSO collaboratively launch a national health awareness campaign

Inovio Biomedical records $2.9 million revenues in the six months ended June 30, 2009

H1N1 vaccine administration coverage for eligible members of Anthem Blue Cross and Blue Shield in Maine

New guidance for businesses to plan for and respond to upcoming flu season

AstraZeneca Canada files a New Drug Submission (NDS) for FluMist in Canada

U.S. Food and Drug Administration launches new Center for Tobacco Products

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Influenza News and Research

Latest Influenza News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in